A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis

Annals of Tropical Medicine and Parasitology

Volumn 98, Issue 2, 2004, Pages 129-138

  Thakur, C P ^a   Narayan, S ^a,b  

^a Balaji Utthan Sansthan   (India)

^b RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIMONY GLUCONATE; ASPARTATE AMINOTRANSFERASE; CREATININE; HYDROCORTISONE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; STIBOGLUCONATE SODIUM;

ABSCESS; ADOLESCENT; ADULT; AGED; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BONE MARROW BIOPSY; CARDIOTOXICITY; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG INFUSION; DRUG SCREENING; DRUG SENSITIVITY; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; HEART ARREST; HEART MUSCLE INJURY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INJECTION SITE; LEUKOCYTE CULTURE; LEUKOPENIA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; MYOCARDITIS; NONHUMAN; OUTCOMES RESEARCH; PROMASTIGOTE; RIGOR; SHIVERING; THROMBOCYTOPENIA; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; BONE MARROW; CELLS, CULTURED; CHILD; FEMALE; HUMANS; INDIA; INFUSIONS, PARENTERAL; INJECTIONS, INTRAMUSCULAR; LEISHMANIASIS, VISCERAL; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; TREATMENT OUTCOME;

ANIMALIA; PROTOZOA;

EID: 1642304536     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349804225003154     Document Type: Article

References (43)

1. Berman, J. D. Chulay, J. D., Hendricks, L. D. & Oster, C. N. (1982). Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. American Journal of Tropical Medicine and Hygiene, 31, 459-465.
2. Bhatnagar, A., Guru, P. Y. Katiyar, J. C., Srivastava, R., Mukherjee, A., Akhtar, H. S., Seth, M. & Bhaduri, A. P. (1989). Exploration of antileishmanial activity in heterocycles, results of their in vitro and in vivo bio-evaluations. Indian Journal of Medical Research, 89, 439-444.
3. Bradley, D. J. & Kirkely, J. (1977). Regulation of Leishmania population within the host. The variable course of Leishmania donovani infection in mice. Clinical and Experimental Immunology, 30, 119-129.
4. Chang, K. P. (1980). Human cutaneous Leishmania in mouse macrophage line. Propagation and isolation of intracellular parasites. Science, 209, 240-242.
5. Chuley, J. D. & Bryceson, A. D. M. (1983). Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 32, 475-479.
6. Dedet, J. P. & Pratlong, F. (2003). Leishmaniasis. In Manson's Tropical Diseases, 21st Edn, eds Cook, G. C. & Zumla, A. I. pp. 1339-1363. Edinburgh: Elsevier Science.
7. Dowd, J. E. (1979). Health Statistical Methodology. In Report of the Workshop on the Chemotherapy of Mucocutaneous Leishmaniasis, ed. de Raadt, P. pp. 17-19. Document TDR/Leish/MCL79.3. Geneva: World Health Organization.
8. Grogl, M., Oduola, A. M. J., Cordero, L. D. & Kyle, D. E. (1989). Leishmania spp: development of pentostam resistant clones in vitro by discontinuous drug exposure. Experimental Parasitology, 69, 78-90.
9. Gupta, P. C. S. (1953). Chemotherapy of leishmanial diseases: a resume of recent researches. Indian Medical Gazette, 88, 20-35.
10. Gupta, P. C. S. (1960). Leishmaniasis. In A Handbook of Tropical Diseases, 6th Edn, eds Banerjee, J. C. & Bhattacharya, P. B. pp. 103-140. Calcutta: Academic Publishers.
11. Handman, E., Hocking, R. E., Mitchell, G. F. & Spithill, T. W. (1983). Isolation and characterization of effective and non-effective clones of Leishmania tropica. Molecular Biochemistry and Parasitology, 7, 111-116.
12. Hart, D. T., Vickerman, K. & Coombs, G. (1981). Transformation in vitro of Leishmania mexicana amastigotes to promastigotes: nutritional requirement and the effect of the drugs. Parasitology, 83, 520-541.
13. Hockmeyer, W. T., Kager, P. A., Rees, P. H. & Hendricks, L. D. (1981). The culture of Leishmania donovani in Schneider's insect medium, its value in the diagnosis and management of patients with visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 75, 861-866.
14. Jha, T. K. (1983). Evaluation of diamidine compounds (pentamidine isetheonate) in the treatment of resistant cases of kala-azar occurring in north Bihar, India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 77, 167-170.
15. Jha, T. K., Olliaro, P., Thakur, C. P., Kanyok, T. P., Singhania, B. L. Singh, N. K., Akhawrya, S. & Jha, S. (1998). Randomized controlled trial of aminosidine (paromomycin) v. sodium stibogluconate for treating visceral leishmaniasis in north Bihar, India. British Medical Journal, 361, 200-205.
16. Lira, R., Sundar, S., Makharia, A., Keeny, R. Gam, A., Saraiva, E. & Sack, D. (1999). Evidence that the high incidence of treatment failure in Indian kalaazar is due to emergence of antimony resistant strains of Leishmania donovani. Journal of Infectious Diseases, 180, 564-567.
17. Manson-Bahr, P. E. C. (1972). Leishmaniasis. In Manson's Tropical Diseases, 17th Edn, eds Wilcocks, C. & Manson-Behr, P. E. C. pp. 117-147. London: English Language Book Society.
18. Mishra, M., Biswas, U. K., Jha, D. N. & Khan, A. B. (1992). Amphotericin versus pentamidine in antimony unresponsive kala-azar patients. Lancet, 340, 1256-1257.
19. Peters, W. (1981). The treatment of kala-azar - new approach to an old problem. Indian Journal of Medical Research, 73 (Suppl.), 1-18.
20. Ritmeijer, K., Veeken, H., Melaku, Y., Leal, G., Amsalu, R., Seaman, J. & Davidson, R. N. (2001). Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 668-672.
21. Schneider, C. R. & Hertig, H. (1996). Immunodiffusion reactions of Panamanian Leishmania. Experimental Parasitology, 8, 25-34.
22. Singh, N, Singh, R. T. & Sundar, S. (2002). Identification of a gene linked to drug resistance in field isolates of Leishmania donovani. Annals of Tropical Medicine and Parasitology, 96, 839-841.
23. Sundar, S., Sinha, P. R., Agrawal, N. K., Srivastava, R., Rainey, P. M., Berman, J. D., Murray, H. W. & Singh, V. P. (1998). A cluster of severe antimony cardiac toxicity in kala-azar due to high osmolality lot. American Journal of Tropical Medicine and Hygiene, 59, 139-143.
24. Sundar, S., More, D. K., Singh, M. K., Singh, V. P., Sharma, S., Makharia, A., Kumar, P. C. K. & Murray, H. W. (2000). Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clinical Infectious Diseases, 31, 1104-1107.
25. Thakur, C. P. (1984). Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Transactions of the Royal Society of Tropical Medicine and Hygiene, 78, 391-398.
26. Thakur, C. P. (1993). Diminishing effectiveness of currently used drugs in the treatment of kala-azar and amphotericine B in antimony and pentamidine resistant kala-azar. In Trends in Leishmania Research, eds Bhaduri, A. N., Basu, M. K., Sen, A. K. & Kumar, S. pp. 234-262. New Delhi: Council of Scientific and Industrial Research.
27. Thakur, C. P. (1995). Correction of serum electrolytes imbalance prevents cardiac anrrhythmia during amphotericin B administration. National Medical Journal of India, 8, 13-14.
28. Thakur, C. P. (1998). Sodium antimony gluconate, amphotericin, and myocardial damage. Lancet, 351, 1928-1929.
29. Thakur, C. P. & Kumar, M. (1992). Observations on the effect of verapamil with sodium stibogluconate in kala-azar. Tropical and Geographical Medicine, 44, 15-16.
30. Thakur, C. P., Kumar, M., Singh, S. K., Sharma, D., Prasad, U. S., Singh, R. S. P., Dhawan, P. S. & Achari, V. (1984). Comparison of regimens of treatment with sodium stibogluconate in kala-azar. British Medical Journal, 288, 895-897.
31. Thakur, C. P., Kumar, M., Kumar, P., Mishra, B. N. & Pandey, A. K. (1988). Rationalization of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomized study. British Medical Journal, 296, 1557-1561.
32. Thakur, C. P., Kumar, M. & Pandey, A. K. (1991). Comparison of regimes of treatment of antimony resistant kala-azar patients: a randomized study. American Journal of Tropical Medicine and Hygiene, 45, 435-441.
33. Thakur, C. P., Sinha, G. P., Barat, D. & Singh, R. K. (1994a). Daily versus alternate day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison. Bulletin of the World Health Organization, 72, 931-936.
34. Thakur, C. P., Sinha, G. P., Barat, D. & Singh, R. K. (1994b). Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis? Annals of Tropical Medicine and Parasitology, 88, 365-370.
35. Thakur, C. P., Sinha, G. P., Barat, D. & Singh, R. K. (1995). Two hours versus six hours administration of amphotericin B in the treatment of kala-azar. International Journal of Antimicrobial Agents, 51, 115-117.
36. Thakur, C. P., Sinha, G. P. & Pandey, A. K. (1996). Comparison of regimens of amphotericin B deoxycholate in kala-azar. Indian Journal of Medical Research, 103, 259-263.
37. Thakur, C. P., Sinha, G. P., Pandy, A. K., Kumar, N., Kumar, P., Hassan, S. M., Narain, S. & Roy, R. K. (1998). Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first line drug? An observational study of 80 cases. Annals of Tropical Medicine and Parasitology, 92, 561-569.
38. Thakur, C. P., Kanyok, T. P., Pandey, A. K., Sinha, G. P., Zaniewski, A. C., Houlihan, H. H. & Olliaro, P. (2000). A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibocluconate alone for the treatment a visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 429-431.
39. Thakur, C. P., Dedet, J. P., Narayan, S. & Pratlong, F. (2001). Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 78, 391-398.
40. Trotter, E. R., Peters, W. & Robinson, B. L. (1980). The experimental chemotherapy of leishmaniasis. The development of rodent model for visceral infection. Annals of Tropical Medicine and Parasitology, 74, 127-138.
41. Vasudevan, G., Ullman, B. & Landfear, S. M. (2001). Point mutation in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity. Proceedings of the National Academy of Sciences of the United States of America, 98, 6092-6097.
42. Veeken, H., Ritmeijer, R., Seaman, J. & Davidson, R. N. (2000). Randomised comparison of branded sodium stiboglucoate (Pentostam, Glaxo-Wellcome, London) and generic sodium stibogluconate (Albert David Ltd. Calcutta) for the treatment of visceral leishmaniasis under field conditions in Sudan. Tropical Medicine and International Health, 5, 312-319.
43. World Health Organization (1990). Control of Leishmaniasis. Technical Report Series No. 793. Geneva: WHO.